The theoretical threat from blood pressure medicine’s effects on COVID-19 caused many patients on these medications to make panicked calls to their healthcare providers. However, a group of professional associations and researchers moved quickly to counter this fear — and to recommend that patients infected with COVID-19 should continue taking renin-angiotensin system (RAS) blockers in...
Author: Mark Newman
Endocrine Society Argues for Inclusion of EDCs in EU Chemicals Strategy
In May, the European Commission released a roadmap outlining plans for a Chemicals Strategy for Sustainability. The Chemicals Strategy, which will form a component of the European Green Deal, seeks to “reduce the risks associated with producing and using chemicals” by improving the European Union (EU) regulatory process and strengthening the regulatory framework for harmful...
On June 11, the National Institutes of Health (NIH) announced the appointment of Rick Woychik, PhD, as director of the National Institute of Environmental Health Sciences (NIEHS) and National Toxicology Program (NTP). Woychik has been serving as the Acting Director of NIEHS since October 2019 following the retirement of the previous Director, Linda Birnbaum, PhD....
The Endocrine Society’s Role in Recent LGBTQ+ Supreme Court Ruling
In a landmark ruling, the Supreme Court of the United States found that gay and transgender individuals cannot be discriminated against in the workplace on the basis of sex. The 6-3 decision stated that Title VII of the Civil Rights Act of 1964, which prohibits discrimination “because of sex,” includes gay and transgender employees. The...
Diabetic Ketoacidosis Threatens Hospitalized COVID-19 Patients
Diabetic ketoacidosis is a common and potentially fatal complication in hospitalized patients with COVID-19, according to a new clinical perspective published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Diabetic ketoacidosis almost always requires special care in the hospital which usually takes place in the intensive care unit (ICU). It is caused by insufficient insulin circulating in the bloodstream, which is more likely to occur during a serious infection like COVID-19. Diabetic...
Endocrine Society Issues Statement on Dexamethasone & COVID-19
On June 17, the Endocrine Society issued a statement on the efficacy of using dexamethasone in COVID-19 patients. Here is the statement in full: A new clinical trial out of the University of Oxford, United Kingdom, reports that dexamethasone reduced deaths in patients with severe COVID-19. It is imperative that our patients and the public...
Mild Thyroid Dysfunction Affects One in Five Women with a History of Miscarriage or Subfertility
Mild thyroid abnormalities affect up to one in five women with a history of miscarriage or subfertility which is a prolonged time span of trying to become pregnant, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Thyroid disorders are common in women of reproductive age. Although the prevalence of thyroid disorders in pregnancy are well understood,...
Endocrine Society Holds Anti-Racism Vigil During ENDO Online 2020
On June 16, the Endocrine Society held an Anti-Racism Vigil as part of its ongoing virtual annual meeting, ENDO Online 2020. The Society believes that Black Lives Matter and so shared comments from our current president, Gary Hammer, MD, PhD; our president-elect, Carol Wysham, MD; and our immediate past president, E. Dale Abel, MD, PhD;...